Earning trust with your own body is not
How to Taper Off GLP-1 Medications Safely Stopping GLP-1 medications like Wegovy, Ozempic, or Mounjaro suddenly can lead to significant weight regain and health issues
Understanding their mechanisms, benefits, and associated risks will remain essential as their role in clinical medicine continues to expand
Medical Conditions That May Qualify You If your BMI is between 27-29.9, you may still qualify for GLP-1 medications if you have: Type 2 diabetes or prediabetes High blood pressure (hypertension) High cholesterol or dyslipidemia Sleep apnea Cardiovascular disease Metabolic syndrome Insulin resistance These conditions are often interconnected with weight, and GLP-1 for weight loss can help address multiple health concerns simultaneously
AstraZeneca PLC is a biopharmaceutical company that researches, develops, manufactures, and sells prescription drugs
Their indications have since expanded to include obesity and metabolic syndrome X, fundamentally changing the medical paradigm